We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
- Authors
Keating, Nancy L; O'Malley, A James; Smith, Matthew R
- Abstract
Androgen deprivation therapy with a gonadotropin-releasing hormone (GnRH) agonist is associated with increased fat mass and insulin resistance in men with prostate cancer, but the risk of obesity-related disease during treatment has not been well studied. We assessed whether androgen deprivation therapy is associated with an increased incidence of diabetes and cardiovascular disease.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 27, p4448
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.06.2497